Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!
作者信息
Curigliano Giuseppe, Eggermont Alexander M M
机构信息
European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hematology, University of Milan, Milan, Italy.
Princess Máxima Center, Utrecht, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands.
出版信息
Eur J Cancer. 2021 Aug;153:257-259. doi: 10.1016/j.ejca.2021.05.007. Epub 2021 May 24.
Abstract
摘要
相似文献
1
Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!癌症患者对新冠疫苗的依从性：促进并实现它！
Eur J Cancer. 2021 Aug;153:257-259. doi: 10.1016/j.ejca.2021.05.007. Epub 2021 May 24.
2
SARS-CoV-2 vaccines for cancer patients: a call to action.癌症患者的 SARS-CoV-2 疫苗：行动呼吁。
Eur J Cancer. 2021 May;148:316-327. doi: 10.1016/j.ejca.2021.01.046. Epub 2021 Feb 25.
3
The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer.老年肿瘤患者新冠疫苗接种：国际老年肿瘤学会（SIOG）新冠工作组建议
J Geriatr Oncol. 2021 Jun;12(5):848-850. doi: 10.1016/j.jgo.2021.03.003. Epub 2021 Mar 5.
4
An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations.SARS-CoV-2 大流行公众意识对癌症患者 COVID-19 疫苗接种依从性影响的最新进展：结果和建议。
Front Public Health. 2022 Jul 22;10:923815. doi: 10.3389/fpubh.2022.923815. eCollection 2022.
5
Commentary: SARS-CoV-2 vaccines and cancer patients.评论：严重急性呼吸综合征冠状病毒2型疫苗与癌症患者
Ann Oncol. 2021 Apr;32(4):569-571. doi: 10.1016/j.annonc.2020.12.019. Epub 2021 Jan 12.
6
COVID-19 vaccination for cancer patients: Evidence, priority, and practice.癌症患者的新冠病毒疫苗接种：证据、优先级及实践
Vaccine. 2021 Aug 23;39(36):5075-5077. doi: 10.1016/j.vaccine.2021.07.063. Epub 2021 Jul 24.
7
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
8
[We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment].正在接受治疗的癌症患者必须立即遵守抗SARS-CoV-2疫苗接种计划。
Bull Cancer. 2021 Apr;108(4):341-342. doi: 10.1016/j.bulcan.2021.02.003. Epub 2021 Mar 5.
9
COVID-19 vaccines in patients with cancer.癌症患者的新冠病毒疫苗接种情况
Lancet Oncol. 2021 Jun;22(6):738-739. doi: 10.1016/S1470-2045(21)00250-3.
10
COVID-19 Vaccine Guidance for Patients with Cancer in Mexico: Report From the Working Group of the Mexican Society of Oncology.墨西哥癌症患者的COVID-19疫苗接种指南：墨西哥肿瘤学会工作组报告
Arch Med Res. 2022 Feb;53(2):223-227. doi: 10.1016/j.arcmed.2021.07.005. Epub 2021 Jul 30.
引用本文的文献
1
Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine.癌症患者接种 2 剂 mRNA COVID-19 疫苗后的不良事件报告。
J Natl Compr Canc Netw. 2022 Feb;20(2):160-166. doi: 10.6004/jnccn.2021.7113.
2
COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study.科威特接受生物疗法的炎症性肠病患者对COVID-19疫苗的犹豫态度：一项横断面研究。
Vaccines (Basel). 2021 Dec 31;10(1):55. doi: 10.3390/vaccines10010055.
3
SARS-CoV-2 spike protein inhibits growth of prostate cancer: a potential role of the COVID-19 vaccine killing two birds with one stone.SARS-CoV-2 刺突蛋白抑制前列腺癌生长：COVID-19 疫苗一石二鸟的潜在作用。
Med Oncol. 2022 Jan 20;39(3):32. doi: 10.1007/s12032-021-01628-1.
4
Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.评估癌症患者的 COVID-19 疫苗反应：一项中期分析。
Eur J Cancer. 2021 Dec;159:259-274. doi: 10.1016/j.ejca.2021.10.013. Epub 2021 Oct 25.
5
Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.接种 COVID-19 疫苗后癌症患者的血清转化率：系统评价。
Ann Oncol. 2022 Feb;33(2):158-168. doi: 10.1016/j.annonc.2021.10.014. Epub 2021 Oct 28.
6
COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in Italy.COVID-19 疫苗在接受积极治疗的实体瘤成年癌症患者中的应用：血清阳性率和安全性。意大利的一项前瞻性观察研究。
Eur J Cancer. 2021 Nov;157:441-449. doi: 10.1016/j.ejca.2021.08.035. Epub 2021 Sep 2.
7
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix.严重急性呼吸综合征冠状病毒2疫苗接种与癌症治疗：成功但需谨慎的组合。
Eur J Cancer. 2021 Oct;156:119-121. doi: 10.1016/j.ejca.2021.07.038. Epub 2021 Aug 5.
8
Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer.当前提高正在接受癌症积极治疗的患者对 SARS-CoV-2 疫苗效力的观点。
Eur J Cancer. 2021 Sep;154:66-72. doi: 10.1016/j.ejca.2021.06.008. Epub 2021 Jun 18.
9
The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.BNT162b2 mRNA COVID-19 疫苗在青少年和年轻癌症患者中的应用：一项单中心经验。
Eur J Cancer. 2021 Sep;154:30-34. doi: 10.1016/j.ejca.2021.06.002. Epub 2021 Jun 23.
本文引用的文献
1
SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.在多民族的英国医疗保健工作者中，对 SARS-CoV-2 疫苗的接种情况：一项横断面研究。
PLoS Med. 2021 Nov 5;18(11):e1003823. doi: 10.1371/journal.pmed.1003823. eCollection 2021 Nov.
2
COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout.第四家批准使用 BNT162b2 疫苗的国家，在推出疫苗的第一个月内医护人员对 COVID-19 疫苗的接种情况。
Vaccine. 2021 Sep 24;39(40):5762-5768. doi: 10.1016/j.vaccine.2021.08.083. Epub 2021 Sep 2.
3
The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.意大利首例实体瘤癌症患者拒绝接种 2019 冠状病毒疾病（COVID-19）疫苗报告：单中心调查的早期数据。
Eur J Cancer. 2021 Aug;153:260-264. doi: 10.1016/j.ejca.2021.05.006. Epub 2021 May 26.
4
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.癌症患者接种一剂与两剂新冠疫苗BNT162b2的安全性和免疫原性：一项前瞻性观察研究的中期分析
Lancet Oncol. 2021 Jun;22(6):765-778. doi: 10.1016/S1470-2045(21)00213-8. Epub 2021 Apr 27.
5
COVID-19 and cancer: 1 year on.新冠疫情与癌症：一年之后
Lancet Oncol. 2021 Apr;22(4):411. doi: 10.1016/S1470-2045(21)00148-0.
6
SARS-CoV-2 vaccines for cancer patients: a call to action.癌症患者的 SARS-CoV-2 疫苗：行动呼吁。
Eur J Cancer. 2021 May;148:316-327. doi: 10.1016/j.ejca.2021.01.046. Epub 2021 Feb 25.
7
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes.SARS-CoV-2 疫苗接种方案的流行病学和进化考虑。
Science. 2021 Apr 23;372(6540):363-370. doi: 10.1126/science.abg8663. Epub 2021 Mar 9.
8
COVID-19 Vaccination Acceptance and Hesitancy in Dialysis Staff: First Results From New York City.透析工作人员对 COVID-19 疫苗的接受度及犹豫情况：来自纽约市的初步结果
Kidney Int Rep. 2021 Apr;6(4):1192-1193. doi: 10.1016/j.ekir.2021.02.001. Epub 2021 Feb 12.
9
Vaccination rates and acceptance of SARS-CoV-2 vaccination among U.S. emergency department health care personnel.美国急诊科医护人员的新冠病毒疫苗接种率及对新冠病毒疫苗的接受情况。
Acad Emerg Med. 2021 Apr;28(4):455-458. doi: 10.1111/acem.14236. Epub 2021 Mar 15.
10
On the reliability of predictions on Covid-19 dynamics: A systematic and critical review of modelling techniques.关于新冠疫情动态预测的可靠性：建模技术的系统与批判性综述
Infect Dis Model. 2021;6:258-272. doi: 10.1016/j.idm.2020.12.008. Epub 2021 Jan 12.
Zotero 插件